Merck Acquires Much Needed Diversification With $10.8bn Prometheus Buy

$200 Per Share Buyout Is 75% Premium

 
• By Mandy Jackson
  
Pain in human intestines, bowel concept
PRA023 will move into Phase III in ulcerative colitis and Crohn's disease in late 2023 or early 2024 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business